Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Evolus Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evolus (EOLS – Research Report) and Krystal Biotech ...

Analysts Are Bullish on Top Healthcare Stocks: Evolus (EOLS), Krystal Biotech (KRYS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evolus (EOLS – Research Report) and Xenon (XENE – ...

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Xenon (XENE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cartesian Therapeutics (RNAC – Research Report), Evo...

Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Evolus (EOLS) and Dexcom (DXCM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR – Research Report)...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EOLS	$4.91	-3.35%	609.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EOLS	$4.91	-3.3%	609.47K
3
4
5
6

EOLS

EOLS

Get Evolus Inc. Data in Excel

Get Evolus Inc. Data in Excel